Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
32.42
+0.60 (1.89%)
At close: Jan 17, 2025, 4:00 PM
32.71
+0.29 (0.89%)
Pre-market: Jan 21, 2025, 9:06 AM EST
Agios Pharmaceuticals Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$56.33
Upside
+73.75%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Dec 18, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $55 → $57 | Buy | Maintains | $55 → $57 | +75.82% | Dec 10, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $53 → $75 | Buy | Maintains | $53 → $75 | +131.34% | Dec 9, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $55 | Buy | Reiterates | $55 | +69.65% | Nov 1, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $51 → $53 | Buy | Maintains | $51 → $53 | +63.48% | Nov 1, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $51 | Buy | Initiates | $51 | +57.31% | Oct 16, 2024 |
| Raymond James | Raymond James | Buy Initiates $51 | Buy | Initiates | $51 | +57.31% | Oct 10, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $60 → $56 | Buy → Hold | Downgrades | $60 → $56 | +72.73% | Sep 27, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 20, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $55 | Buy | Reiterates | $55 | +69.65% | Sep 19, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $53 → $55 | Buy | Maintains | $53 → $55 | +69.65% | Aug 2, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 17, 2024 |
| JP Morgan | JP Morgan | Hold Initiates $46 | Hold | Initiates | $46 | +41.89% | Jun 13, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $33 → $53 | Hold | Maintains | $33 → $53 | +63.48% | Jun 4, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $44 → $53 | Buy | Maintains | $44 → $53 | +63.48% | Jun 4, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $29 → $33 | Hold | Maintains | $29 → $33 | +1.79% | May 3, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.